Previous Close | 1.8500 |
Open | 0.0000 |
Bid | 1.7000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.0000 - 0.0000 |
52 Week Range | |
Volume | |
Avg. Volume | 139,645 |
Market Cap | 17.257M |
Beta (5Y Monthly) | 0.64 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.4000 |
Earnings Date | Mar 21, 2023 - Mar 27, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
On a positive note, Medtronic (MDT) registers organic growth in the Cardiovascular and Neuroscience segments.
Medtronic (NYSE: MDT) may be a leader in the medical device space, but its sluggish 1.3% revenue growth over the past three years has not kept pace with the 5% growth of the medical device market. Medtronic's Surgical Innovations segment achieved robust growth over the past year. Its 9% revenue growth overshadowed the 2%-3% revenue growth from the Cardiovascular and Neuroscience segments.
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...